Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

b29ceb0b4c08d0e8f63f204944dcc7.HeZ2iyZsqipd4afz6oevRlqV7RWMZ4Z_op7-LjOmeDY.cLZb238FnEUOzMS6of_3ByPQoyz5C74P6fSLGGX5M29Znx7UZSbsYD6s_g~7150e1f25f34cf6b84098a0e204e5fd2
18/08 Leerink Partners Adjusts Price Target on Stryker to $403 From $407, Maintains Outperform Rating MT
13/08 Citigroup Adjusts Price Target on Stryker to $399 From $385, Maintains Buy Rating MT
05/08 Rothschild & Co Redburn Adjusts Stryker Price Target to $360 From $346 MT
03/08 UBS Adjusts Stryker Price Target to $382 From $400, Maintains Buy Rating MT
03/08 Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power... Zonebourse
31/07 RBC Cuts Price Target on Stryker to $420 From $435, Keeps Outperform Rating MT
31/07 Evercore ISI Adjusts Stryker Price Target to $355 From $350, Maintains Outperform Rating MT
31/07 Truist Lifts Price Target on Stryker to $340 From $330, Keeps Hold Rating MT
31/07 Raymond James Adjusts Price Target on Stryker to $370 From $383, Maintains Outperform Rating MT
31/07 Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating MT
31/07 BTIG Adjusts Price Target on Stryker to $358 From $371, Maintains Buy Rating MT
31/07 Piper Sandler Adjusts Price Target on Stryker to $390 From $420, Maintains Overweight Rating MT
31/07 JPMorgan Adjusts Price Target on Stryker to $350 From $400, Maintains Overweight Rating MT
31/07 Bernstein Adjusts Price Target on Stryker to $420 From $410, Maintains Outperform Rating MT
30/07 The Fed Gets a Better Inflation Number Zonebourse
28/07 UBS Upgrades Stryker to Buy From Neutral, Adjusts Price Target to $400 From $380 MT
14/07 Goldman Sachs Adjusts Price Target on Stryker to $339 From $363, Maintains Neutral Rating MT
13/07 BTIG Research Adjusts Stryker Price Target to $371 From $379, Maintains Buy Rating MT
09/07 Argus Research Adjusts Stryker Price Target to $370 From $350 MT
09/07 BMO Capital Initiates Coverage on Stryker With Outperform Rating, $369 Price Target MT
06/07 Evercore ISI Adjusts Price Target on Stryker to $350 From $355 MT
05/06 Leerink Partners Adjusts Price Target on Stryker to $407 From $410, Maintains Outperform Rating MT
27/05 Goldman Sachs Adjusts Price Target on Stryker to $363 From $361, Maintains Neutral Rating MT
13/05 Rothschild & Redburn Co Adjusts Price Target on Stryker to $346 From $420, Maintains Neutral Rating MT
12/05 Argus Adjusts Price Target on Stryker to $350 From $435, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+26.26%
+19.3%
+11.09%
+42.67%
- - +26.15%
-4.25%
+46.13%
- - -
Average +23.91%
Weighted average by Cap. +24.92%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
303.13USD
Average target price
382.72USD
Spread / Average Target
+26.26%
High Price Target
465.00USD
Spread / Highest target
+53.40%
Low Price Target
315.00USD
Spread / Lowest Target
+3.92%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
AA
  1. Stock Market
  2. Stocks
  3. SYK Stock
  4. Consensus Stryker Corporation
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!